Skip to main content
Home
language-selector-globe Malaysia | en
Choose Location
  • Americas
  • Asia Pacific
  • Europe
  • International
  • Middle East & Africa
Argentina | Español
Brazil | Português
Canada | English
Canada | Français
Central America | Español
Colombia | Español
Mexico | Español
United States | English
Australia | English
Bangladesh | English
Hong Kong S.A.R. | 繁體中文
India | English
Indonesia | English
Japan | 日本語
Korea | 한국어
Mainland China | 中文
Malaysia | English
Pakistan | English
Philippines | English
Singapore | English
Taiwan | 繁體中文
Thailand | ภาษาไทย
Austria | Deutsch
Belgium | Français
Belgium | Nederlands
Bulgaria | Български
Czech Republic | Česky
Czech Republic | English
Denmark | Dansk
Estonia | Eesti
Finland | Suomalainen
France | Français
Germany | Deutsch
Greece | Ελληνικά
Hungary | Magyar
Ireland | English
Italy | Italiano
Latvia | Latvian
Lithuania | Lithuanian
Netherlands | Nederlands
Norway | Norsk
Poland | Polski
Portugal | Português
Romania | Română
Russia | Русский
Serbia | Srpski
Slovakia | Slovensky
Slovenia | Slovenščina
Slovenia | English
Spain | Español
Sweden | Svenska
Switzerland | Deutsch
Switzerland | Français
Türkiye | Türkçe
United Kingdom | English
Global | English
Novartis Foundation | English
Egypt | English
Israel | עברית
Saudi Arabia | العربية
South Africa | English
language-selector-globe Malaysia
Choose Location
Americas Asia Pacific Europe International Middle East & Africa
Argentina | Español
Australia | English
Austria | Deutsch
Bangladesh | English
Belgium | Français
Belgium | Nederlands
Brazil | Português
Bulgaria | Български
Canada | English
Canada | Français
Central America | Español
Colombia | Español
Czech Republic | Česky
Czech Republic | English
Denmark | Dansk
Egypt | English
Estonia | Eesti
Finland | Suomalainen
France | Français
Germany | Deutsch
Greece | Ελληνικά
Hong Kong S.A.R. | 繁體中文
Hungary | Magyar
India | English
Indonesia | English
Ireland | English
Israel | עברית
Italy | Italiano
Japan | 日本語
Korea | 한국어
Latvia | Latvian
Lithuania | Lithuanian
Mainland China | 中文
Malaysia | English
Mexico | Español
Netherlands | Nederlands
Norway | Norsk
Global | English
Novartis Foundation | English
Pakistan | English
Philippines | English
Poland | Polski
Portugal | Português
Romania | Română
Russia | Русский
Saudi Arabia | العربية
Serbia | Srpski
Singapore | English
Slovakia | Slovensky
Slovenia | Slovenščina
Slovenia | English
South Africa | English
Spain | Español
Sweden | Svenska
Switzerland | Deutsch
Switzerland | Français
Taiwan | 繁體中文
Thailand | ภาษาไทย
Türkiye | Türkçe
United Kingdom | English
United States | English
    • About 
      • Novartis in Malaysia 
      • Country Leadership Team 
      • Products 
      • Therapeutic Areas 
      • People and Culture 
      • Diversity, Equity and Inclusion 
      • Awards and Recognition 
      Kuala Lumpur About
    • Patients and caregivers 
      • Novartis Commitment to Patients and Caregivers 
      • Diseases 
      • Adverse Event Reporting 
      • Our Process 
      Patient and Doctor Patients and Caregivers
    • Healthcare professionals 
      • Healthcare professional country resource 
      • Novartis Pipeline 
      • Adverse Event Reporting 
      • Novartis Clinical Trials 
      Screenshot 2024 07 10 at 7.24 Healthcare Professionals
    • ESG 
      • Ethical Behavior 
        • Code of Ethics 
        • SpeakUp 
      • Ethics, Risk and Compliance 
      • Access 
      • Environmental Sustainability 
      • Global Health 
      Screenshot 2024 07 10 at 7.14 ESG
    • News 
      • Stories 
      • News Archive 
      Discussion News
    • Careers 
      • Career Search 
      • Meet the Teams 
      • Early Talent 
      • How We Work 
      • Wellbeing 
      Screenshot 2022 03 17 at 09.29 Careers Careers
    • Contact 
    Contacts Contact Us
  1. Home
  2. Careers
  3. Career Search
  • Sort by Sort ascending
  • Job Title
  • Site
  • Location
  • Division
  • Business Sort descending
  • Functional Area
  • Date Posted
Job Title Site Location Division Business Sort descending Functional Area Date Posted
Order Management Specialist - Temporary INSURGENTES Mexico Finance CTS Audit & Finance Sep 25, 2024
Analyst - SFE Products Hyderabad (Office) India Operations CTS Marketing May 20, 2024
Associate, Record-to-Report Head Office (Japan) (Pharmaceuticals) Japan Finance CTS Audit & Finance Jun 26, 2024
Senior Specialist DDIT OPS Mfg Site IT Sasayama Japan Operations CTS Information Technology Jul 22, 2024
Manager, Financial Control & Compliance (FC&C) Head Office (Japan) (Pharmaceuticals) Japan Finance CTS Audit & Finance Oct 06, 2024
R2R Accountant Moscow (City) Russian Fed. Finance CTS Audit & Finance Jul 25, 2024
Analyst - SFE Products Hyderabad (Office) India Operations CTS Marketing May 20, 2024
Analyst - SFE Products Hyderabad (Office) India Operations CTS Marketing May 20, 2024
Analyst - SFE Products Hyderabad (Office) India Operations CTS Marketing May 20, 2024
Revenue Accounting Manager Shanghai (Shanghai) China Finance CTS Audit & Finance Jul 17, 2024
Sales Representative (w/m/d), TA: Immunologie, Gebiet: Brandenburg Brandenburg (Novartis Pharma GmbH) Germany International Innovative Medicines Sales Oct 16, 2024
Netzwerk Manager (m/w/d), Prostate Cancer, Saarland und Rheinland-Pfalz Saarland (Novartis Pharma GmbH) Germany International Innovative Medicines Sales Oct 16, 2024
(高级)医药代表 /(资深)产品专员 Kuerle (Xinjiang Province) China International Innovative Medicines Sales Oct 16, 2024
Sales Representative Neuroscience (m/w/d) Hessen Hessen (Novartis Pharma GmbH) Germany International Innovative Medicines Sales Oct 17, 2024
Produktionsmitarbeiter (m/w/d), Kundl, Austria Kundl Austria Operations Innovative Medicines Technical Operations Oct 17, 2024
Schichtführer-Stellvertreter (m/f/d), Kundl, Tirol, Österreich Kundl Austria Operations Innovative Medicines Technical Operations Oct 17, 2024
Schichtführer-Stellvertreter (m/f/d), Kundl, Tirol, Austria Kundl Austria Operations Innovative Medicines Technical Operations Oct 17, 2024
MR Changsha (Hunan Province) China International Innovative Medicines Sales Oct 17, 2024
Business Excellence & Execution IM Head, Mexico INSURGENTES Mexico International Innovative Medicines Marketing Oct 17, 2024
Senior/Advanced Medical/Sales Representative Beijing (Beijing) China International Innovative Medicines Sales Oct 17, 2024
Compliance & Quality System Manager Ivrea Italy Operations Innovative Medicines Quality Oct 17, 2024
Equipment Specialist (m/w/d), Kundl, Tirol, Österreich Kundl Austria Operations Innovative Medicines Technical Operations Oct 18, 2024
Director Science & Technology Basel (City) Switzerland Development Innovative Medicines Research & Development Oct 16, 2024
HealthTech Solutions Manager Metamorfosis Greece International Innovative Medicines Marketing Oct 16, 2024
In-Market Brands Lead Jordan Jordan International Innovative Medicines BD&L & Strategic Planning Oct 16, 2024
SSO Study Start-Up Manager London (The Westworks) United Kingdom Development Innovative Medicines Research & Development Oct 16, 2024
Maintenance Specialist Ivrea Italy International Innovative Medicines Technical Operations Oct 16, 2024
Head of R&D Legal, R&D Transactions and Technical Research & Development Basel (City) Switzerland Legal Innovative Medicines Legal & Intellectual Property & Compl. Oct 16, 2024
Director, Development Unit Management Basel (City) Switzerland Development Innovative Medicines Research & Development Oct 16, 2024
Senior Pharmareferent (m/w/d), Onkologie / Urologie / RLT, Gebiet: Rheinland-Pfalz & Saarland Saarland (Novartis Pharma GmbH) Germany International Innovative Medicines Sales Oct 16, 2024
Commissioning & Qualification Engineer Warehouse & Logistics (m/w/d) Schaftenau Austria Operations Innovative Medicines Technical Operations Oct 16, 2024
Manager, Value Stream Morris Plains USA Operations Innovative Medicines Technical Operations Oct 16, 2024
GCP Inspection Project Manager London (The Westworks) United Kingdom Development Innovative Medicines Quality Oct 16, 2024
Marketing Specialist Montreal Canada International Innovative Medicines Marketing Oct 16, 2024
Associate Director, Access & Reimbursement Oncology - Remote - TX,OK, AR Field Non-Sales (USA) USA US Innovative Medicines Market Access Oct 16, 2024
Senior Expert Science & Technology, Analytical Development East Hanover USA Development Innovative Medicines Research & Development Oct 16, 2024
AD, Market Access TA Strategy- Breast & Women's Cancer East Hanover USA US Innovative Medicines Market Access Oct 16, 2024
Associate Director, Marketing Strategist - Immunology East Hanover USA US Innovative Medicines Marketing Oct 16, 2024
(高级)医药代表 /(资深)产品专员 Kuerle (Xinjiang Province) China International Innovative Medicines Sales Oct 16, 2024
Medical Science Liaison (MSL) Neuroscience Eastern PA, Northern NJ Field Non-Sales (USA) USA US Innovative Medicines Research & Development Oct 17, 2024
Field Product Specialist - Hue Vietnam Vietnam International Innovative Medicines Sales Oct 16, 2024
RA Operational Excellence Junior Associate – MEA Dubai Utd.Arab Emir. Development Innovative Medicines Research & Development Oct 16, 2024
Labortechniker / QC Analyst I (m/f/d) Kundl, Schaftenau Schaftenau Austria Operations Innovative Medicines Quality Oct 17, 2024
Lead, QSRC (Quality System Regulatory Compliance) Tuas South Avenue Singapore Operations Innovative Medicines Quality Oct 17, 2024
Medical Science Liaison - Solid Tumors Bucuresti Romania International Innovative Medicines Research & Development Oct 17, 2024
Ekspert upravljanja kakovosti za proces proizvodnje bioloških učinkovin (m/ž/d) / QA expert for the production process of biological agents (m/f/d) Mengeš Slovenia Operations Innovative Medicines Quality Oct 17, 2024
Technical Services Leader Targu Mures Romania Operations Innovative Medicines Technical Operations Oct 17, 2024
EXT Equipment Specialist-3 Torre Annunziata Italy Operations Innovative Medicines Technical Operations Oct 17, 2024
Skladiščnik (m/ž/d) Mengeš Slovenia Operations Innovative Medicines Technical Operations Oct 17, 2024
Country Patient Safety Head - France Paris Headquarter (Novartis Pharma S.A.S.) France Development Innovative Medicines Research & Development Oct 17, 2024

Pagination

  • ‹ Previous page
  • 1
  • …
  • 7
  • 8
  • 9
  • 10
  • 11
  • 12
  • 13
  • …
  • 42
  • › Next page

Novartis Malaysia

Navigate Novartis
  • Patients & Caregivers
  • Healthcare Professionals
  • ESG
  • News
  • Careers
Media Center
  • Press Releases and Stories
Our Portfolio
  • Novartis Clinical Pipeline
  • Novartis Product Portfolio
Footer Bottom
© 2024 Novartis AG
  • Privacy Policy
  • Terms of Use
  • Cookie Settings
  • Site Map
  • Web Accessibility
Novartis Site Directory
This site is intended for an audience in Malaysia